Hybrid Conferencee

International Conference on Hematology and Red Cell Disorders (ICHRCD - 26)

6th - 7th November 2026 | Manchester, UK

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Manchester. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Manchester event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Manchester conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Manchester, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Manchester."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Molecular Diagnostics for Hematological Disorders

This track will explore the latest innovations in molecular diagnostic techniques for the identification and management of hematological disorders. Emphasis will be placed on the integration of genomic data into clinical practice.

Track 02

Clinical Research Innovations in Red Cell Disorders

This session focuses on recent clinical research findings related to red cell disorders, including anemia and polycythemia. Participants will discuss novel therapeutic approaches and their implications for patient care.

Track 03

Patient Monitoring Strategies in Hematology

This track will address the importance of effective patient monitoring in the management of hematological conditions. Discussions will include the use of technology and biomarkers to enhance patient outcomes.

Track 04

Transfusion Therapy: Current Practices and Future Directions

This session will cover the latest guidelines and practices in transfusion therapy for patients with hematological disorders. The focus will be on safety, efficacy, and emerging alternatives to traditional transfusion methods.

Track 05

Laboratory Techniques in Hematology: Innovations and Challenges

This track will highlight cutting-edge laboratory techniques used in the diagnosis and treatment of hematological disorders. Participants will discuss the challenges faced in implementing these techniques in clinical settings.

Track 06

Translational Research in Hematology: Bridging Bench to Bedside

This session will emphasize the role of translational research in advancing hematology practices. Presentations will focus on how laboratory discoveries are being translated into clinical applications.

Track 07

Biomarker Discovery in Hematological Disorders

This track will explore the identification and validation of biomarkers for hematological disorders. Discussions will include their potential role in diagnosis, prognosis, and treatment response.

Track 08

Therapeutic Strategies for Hematological Malignancies

This session will focus on innovative therapeutic strategies for the treatment of hematological malignancies, including leukemia and lymphoma. Experts will share insights on novel agents and combination therapies.

Track 09

Pediatric Hematology: Unique Challenges and Solutions

This track will address the specific challenges faced in the diagnosis and treatment of hematological disorders in pediatric populations. Emphasis will be placed on tailored therapeutic approaches and long-term management.

Track 10

Hematology in the Era of Personalized Medicine

This session will examine the impact of personalized medicine on the field of hematology. Discussions will focus on how genetic profiling and individualized treatment plans are transforming patient care.

Track 11

Global Perspectives on Hematology and Red Cell Disorders

This track will provide a platform for sharing global insights and experiences in the management of hematological disorders. Participants will discuss disparities in care and strategies for improving outcomes worldwide.